Minoryx Therapeutics closes €51M Series C round co-led by ColumbusVP and CaixaCR. Also backed by CDTI, Fund+, Ysios and current investors
31/05/2022 Press release YSIOS CAPITAL JOINS ITS PORTFOLIO COMPANY. MINORYX THERAPEUTICS, €51 MILLION FINANCING. Ysios Capital participates in the € 51M financing of Minoryx Therapeuticsto support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy(X-ALD) therapy * Funds will support the marketing authorization review process for male patients with AMN and launch…